Laser Acupuncture in Rheumatoid Arthritis Geriatric Patients

May 2, 2021 updated by: A. Sedky, Cairo University
Studying the effect of laser acupuncture on geriatric patients with rheumatoid arthritis

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Cairo, Egypt
        • A. Sedky

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 75 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients referred from physician (immunologist) diagnosed with rheumatoid arthritis.

Exclusion Criteria:

  • Patients having the disease overlapping with other connective tissue diseases, such as systematic lupus erythromatosus and systematic sclerosis.
  • History of malignancies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aerobic exercise
Combination product: Exercise, and methotrexate
Aerobic exercise, and methotrexate
Experimental: Laser acupuncture and aerobic exercise
Combination product: Laser, exercise, and methotrexate
Laser therapy at acupuncture points, aerobic exercise, and methotrexate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Interleukin 6 (IL-6)
Time Frame: Baseline
interleukin 6
Baseline
Interleukin 6 (IL-6)
Time Frame: 4 weeks
interleukin 6
4 weeks
Malondialdehyde (MDA)
Time Frame: Baseline
malondialdehyde
Baseline
Malondialdehyde (MDA)
Time Frame: 4 weeks
malondialdehyde
4 weeks
Adenosine Triphosphate (ATP)
Time Frame: Baseline
adenosine triphosphate
Baseline
Adenosine Triphosphate (ATP)
Time Frame: 4 weeks
adenosine triphosphate
4 weeks
C-Reactive Protein (CRP)
Time Frame: Baseline
C-reactive protein
Baseline
C-Reactive Protein (CRP)
Time Frame: 4 weeks
C-reactive protein
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rheumatoid Arthritis Quality of Life (RAQoL)
Time Frame: Baseline
rheumatoid arthritis quality of life
Baseline
Rheumatoid Arthritis Quality of Life (RAQoL)
Time Frame: 4 weeks
rheumatoid arthritis quality of life
4 weeks
Health Assessment Questionnaire (HAQ)
Time Frame: Baseline
health assessment questionnaire
Baseline
Health Assessment Questionnaire (HAQ)
Time Frame: 4 weeks
health assessment questionnaire
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 20, 2020

Primary Completion (Actual)

December 20, 2020

Study Completion (Actual)

December 22, 2020

Study Registration Dates

First Submitted

February 11, 2021

First Submitted That Met QC Criteria

February 13, 2021

First Posted (Actual)

February 17, 2021

Study Record Updates

Last Update Posted (Actual)

May 6, 2021

Last Update Submitted That Met QC Criteria

May 2, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/002-2021

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rheumatoid Arthritis

Clinical Trials on Laser, exercise, and methotrexate

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe